Universe Pharmaceuticals Inc. Class A Ordinary Shares (UPC)
Stock · NASDAQ · Health Care
$4.02as of 10/16/2026
Price chart
Active signals
UPC Signal Track Record
How signals performed across all stocks →What UPC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakout | 26 | -7.3% | 35% | August 4, 2026 |
| Volume Spike | 22 | -10.8% | 36% | September 1, 2026 |
| Bollinger Band Breakdown | 20 | -22.5% | 35% | May 6, 2026 |
| 200-Day Moving Average TouchActive now | 6 | +4.0% | 67% | July 23, 2026 |
| Any 20-session window (baseline) | -4.2% | 45% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About UPC
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 216
- Website
- www.universe-pharmacy.com/
Fundamentals
- 1-day range
- $3.93$4.1
- Market cap
- $31.35M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- $-10.13
- Dividend yield
- —
- Beta
- 1.76
- Avg. volume
- 786.3K
Universe Pharmaceuticals Inc. Class A Ordinary Shares Competitors
Chosen by industry and closest market cap.
- UPCUniverse Pharmaceuticals Inc. Class A Ordinary Shares$3.93▼ 5.30%Market cap $31.35MP/E —$2$17.96
- QUCYQuantum Cyber N.V. Ordinary Shares$1.06▼ 2.75%Market cap $31.42MP/E —$0.3$4.93
- LITSLite Strategy Inc. Common Stock$1.15▼ 4.17%Market cap $31.61MP/E —$0.6888$2.26
- BCTXBriaCell Therapeutics Corp. Common Shares$3.4▼ 9.81%Market cap $30.01MP/E —$3.68$20.4
- ACTUActuate Therapeutics Inc. Common stock$0.605▲ 21.00%Market cap $29.43MP/E —$0.41$8.27
- ENLVEnlivex Ltd. Ordinary Shares$0.205▼ 8.48%Market cap $33.33MP/E 0.00$0.21$27.15
- MIRAMIRA Pharmaceuticals Inc. Common Stock$0.632▼ 3.95%Market cap $28.50MP/E —$0.6$2.45
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| UPC Universe Pharmaceuticals Inc. Class A Ordinary Shares | $31.35M | — | $3.93 | ▼ 5.30% | $2$17.96 |
| QUCY Quantum Cyber N.V. Ordinary Shares | $31.42M | — | $1.06 | ▼ 2.75% | $0.3$4.93 |
| LITS Lite Strategy Inc. Common Stock | $31.61M | — | $1.15 | ▼ 4.17% | $0.6888$2.26 |
| BCTX BriaCell Therapeutics Corp. Common Shares | $30.01M | — | $3.4 | ▼ 9.81% | $3.68$20.4 |
| ACTU Actuate Therapeutics Inc. Common stock | $29.43M | — | $0.605 | ▲ 21.00% | $0.41$8.27 |
| ENLV Enlivex Ltd. Ordinary Shares | $33.33M | 0.00 | $0.205 | ▼ 8.48% | $0.21$27.15 |
| MIRA MIRA Pharmaceuticals Inc. Common Stock | $28.50M | — | $0.632 | ▼ 3.95% | $0.6$2.45 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · 9/29/2026
- Universe Pharmaceuticals Files Prospectus For Offering $200M Mixed Shelf; 4.377M Class A Ordinary Shares On Behalf Of Selling ShareholdersBenzinga · 9/29/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 9/21/2026
- Discover the top movers in Monday's pre-market session.ChartMill · 9/21/2026
- Lennar Posts Downbeat Q3 Results, Joins Fluence Energy And Other Big Stocks Moving Lower In Thursday’s Pre-Market SessionBenzinga · 9/17/2026
- Why Generac Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving PremarketBenzinga · 9/17/2026
Insider Activity
Insider Actions →See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
UPC Files $200M Shelf Prospectus for Class A Shares
Universe Pharmaceuticals announced a prospectus for a $200 million mixed shelf offering, allowing 4.377 million Class A shares to be sold by existing shareholders. The filing gives the company flexibility to raise capital while giving shareholders an exit option. The move comes as several health‑care stocks, including UPC, moved in Tuesday’s after‑market session, which may influence short‑term trading activity.
UPC Files $200M Shelf Prospectus for Class A Shares. Universe Pharmaceuticals announced a prospectus for a $200 million mixed shelf offering, allowing 4.377 million Class A shares to be sold by existing shareholders. The filing gives the company flexibility to raise capital while giving shareholders an exit option. The move comes as several health‑care stocks, including UPC, moved in Tuesday’s after‑market session, which may influence short‑term trading activity.